3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
4
Prostatic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
SCLC,Extensive Stage
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Metastatic Castration-sensitive Prostate Cancer
1
Laryngeal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Platinum
4
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
atezolizumab
2
Radiotherapy
2
Radiation
2
pembrolizumab
1
decitabine and cedazuridine drug combination
1
cediranib
1
Radiotherapy, Intensity-Modulated
1
Cerebral Decortication
1
Carboplatin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
niraparib
×
30 days
×
Clear all
No trials found.